{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:59:41Z","timestamp":1778104781750,"version":"3.51.4"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81920108010"],"award-info":[{"award-number":["81920108010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171152"],"award-info":[{"award-number":["32171152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900380"],"award-info":[{"award-number":["81900380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Percutaneous adrenal ablation (PAA) is an effective and safe therapy for treating patients with primary aldosteronism (PA). However, its effectiveness in comparison to that of adrenalectomy (ADX) and mineralocorticoid receptor antagonists (MRAs) remains unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>Databases were searched including PubMed, Embase, and The Cochrane Library. Studies included patients with PA who received two of three different treatments (ADX, MRAs, or PAA) and reported our interested outcomes, including blood pressure, serum potassium, and the aldosterone-to-renin ratio (ARR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>In a total of 10,681 patients from 47 studies were identified. Both ADX and PAA showed superior clinical success (systolic blood pressure (BP): ADX: \u22124.69 (\u22126.4, \u22122.95), PAA: \u22123.96 (\u22129.05, 0.99); diastolic BP: ADX: \u22123.14 (\u22124.55, \u22121.85), PAA: \u22122.99 (\u22126.96, 0.98)) compared with MRAs. According to the Bayesian ranking curves (surface under the cumulative ranking values), ADX ranked first for all outcomes of interest (systolic BP: 81.02%, diastolic BP: 76.95%, serum potassium: 96.55%, and ARR: 88.03%), while PAA ranked second for all outcomes (systolic BP: 65.94%, diastolic BP: 69.66%, serum potassium: 50%, and ARR: 45.14%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The findings of this network meta-analysis suggest that PAA could be an alternative treatment for patients with PA who are unable to opt for surgery or MRA therapy, and its clinical and biochemical success falls between those of ADX and MRAs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpaf029","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:18:29Z","timestamp":1741911509000},"page":"654-665","source":"Crossref","is-referenced-by-count":11,"title":["Comparative Outcomes of Adrenalectomy, Mineralocorticoid Receptor Antagonist, and Percutaneous Adrenal Ablation for Primary Aldosteronism: A Systematic Review and Network Meta-Analysis"],"prefix":"10.1093","volume":"38","author":[{"given":"Liyuan","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Hypertension and Endocrinology, Daping Hospital, Center for Hypertension and Metabolic Dieases, Army Medical University of PLA, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[{"name":"School of Mathematics and Statistics, Southwest University , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Endocrinology, Daping Hospital, Center for Hypertension and Metabolic Dieases, Army Medical University of PLA, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Endocrinology, Daping Hospital, Center for Hypertension and Metabolic Dieases, Army Medical University of PLA, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuhao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Endocrinology, Daping Hospital, Center for Hypertension and Metabolic Dieases, Army Medical University of PLA, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Endocrinology, Daping Hospital, Center for Hypertension and Metabolic Dieases, Army Medical University of PLA, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Mathematics and Statistics, Southwest University , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushuang","family":"Luo","sequence":"additional","affiliation":[{"name":"School of Mathematics and Statistics, Southwest University , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Bu","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Endocrinology, Daping Hospital, Center for Hypertension and Metabolic Dieases, Army Medical University of PLA, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongshi","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Endocrinology, Daping Hospital, Center for Hypertension and Metabolic Dieases, Army Medical University of PLA, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Chongqing institute for Brain and Intelligence , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Endocrinology, Daping Hospital, Center for Hypertension and Metabolic Dieases, Army Medical University of PLA, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1035-5588","authenticated-orcid":false,"given":"Zhiming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hypertension and Endocrinology, Daping Hospital, Center for Hypertension and Metabolic Dieases, Army Medical University of PLA, Center for Hypertension and Metabolic Diseases, Chongqing Institute of Hypertension , Chongqing ,","place":["China"]},{"name":"Chongqing institute for Brain and Intelligence , Chongqing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"2025081500464280200_CIT0001","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025081500464280200_CIT0002","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2025081500464280200_CIT0003","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025081500464280200_CIT0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025081500464280200_CIT0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","article-title":"Primary aldosteronism: cardiovascular, renal and metabolic implications","volume":"19","author":"Rossi","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"2025081500464280200_CIT0006","doi-asserted-by":"crossref","first-page":"e1400","DOI":"10.1210\/clinem\/dgaa706","article-title":"Adrenal venous sampling-guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT)","volume":"106","author":"Ohno","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2025081500464280200_CIT0007","doi-asserted-by":"crossref","first-page":"625457","DOI":"10.3389\/fendo.2021.625457","article-title":"Real-world effectiveness of mineralocorticoid receptor antagonists in primary aldosteronism","volume":"12","author":"Tezuka","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025081500464280200_CIT0008","doi-asserted-by":"crossref","first-page":"100676","DOI":"10.1016\/j.tvir.2020.100676","article-title":"\u201cHow We Do It\u201d - a practical approach to percutaneous adrenal ablation techniques","volume":"23","author":"Manchec","year":"2020","journal-title":"Tech Vasc Interv Radiol"},{"key":"2025081500464280200_CIT0009","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/bjs.10219","article-title":"Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma","volume":"103","author":"Liu","year":"2016","journal-title":"Br J Surg"},{"key":"2025081500464280200_CIT0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jvir.2016.03.042","article-title":"Clinical outcomes following percutaneous radiofrequency ablation of unilateral aldosterone-producing adenoma: comparison with adrenalectomy","volume":"27","author":"Sarwar","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"2025081500464280200_CIT0011","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.tvir.2010.02.003","article-title":"Transcatheter renal artery embolization for management of renal and adrenal tumors","volume":"13","author":"Ginat","year":"2010","journal-title":"Tech Vasc Interv Radiol"},{"key":"2025081500464280200_CIT0012","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1148\/radiol.2016152277","article-title":"Aldosterone-producing adenoma in primary aldosteronism: CT-guided radiofrequency ablation-long-term results and recurrence rate","volume":"281","author":"Liu","year":"2016","journal-title":"Radiology"},{"key":"2025081500464280200_CIT0013","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/jch.13960","article-title":"Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: an efficacy and safety, proof-of-principle trial","volume":"22","author":"Zhang","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025081500464280200_CIT0014","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"2025081500464280200_CIT0015","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025081500464280200_CIT0016","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41440-022-01034-8","article-title":"Catheter-based adrenal ablation: an alternative therapy for patients with aldosterone-producing adenoma","volume":"46","author":"Sun","year":"2023","journal-title":"Hypertens Res"},{"key":"2025081500464280200_CIT0017","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.121.054318","article-title":"Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial","volume":"144","author":"Zhao","year":"2021","journal-title":"Circulation"},{"key":"2025081500464280200_CIT0018","doi-asserted-by":"crossref","first-page":"e484","DOI":"10.1210\/clinem\/dgz051","article-title":"Patients with primary aldosteronism respond to unilateral adrenalectomy with long-term reduction in salt intake","volume":"105","author":"Adolf","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025081500464280200_CIT0019","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinimag.2023.04.002","article-title":"Contrast medium free selective adrenal vein sampling in the management of primary aldosteronism","volume":"99","author":"Boschheidgen","year":"2023","journal-title":"Clin Imaging"},{"key":"2025081500464280200_CIT0020","doi-asserted-by":"crossref","first-page":"e13419","DOI":"10.1111\/eci.13419","article-title":"Quality of life in primary aldosteronism: a prospective observational study","volume":"51","author":"Buffolo","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"2025081500464280200_CIT0021","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1007\/s00464-021-08481-3","article-title":"Laparoscopic adrenalectomy vs. radiofrequency ablation for the treatment of primary aldosteronism. A single center retrospective cohort analysis adjusted with propensity score","volume":"36","author":"Cano-Valderrama","year":"2022","journal-title":"Surg Endosc"},{"key":"2025081500464280200_CIT0022","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"2025081500464280200_CIT0023","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/HYPERTENSIONAHA.116.07615","article-title":"Dietary salt intake is a determinant of cardiac changes after treatment of primary aldosteronism: a prospective study","volume":"68","author":"Catena","year":"2016","journal-title":"Hypertension"},{"key":"2025081500464280200_CIT0024","doi-asserted-by":"crossref","first-page":"770711","DOI":"10.3389\/fendo.2021.770711","article-title":"A prospective comparative study on cardiac alterations after surgery and drug treatment of primary aldosteronism","volume":"12","author":"Chen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025081500464280200_CIT0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/clinem\/dgac649","article-title":"Implication of MR activity in posttreatment arterial stiffness reversal in patients with primary aldosteronism","volume":"108","author":"Chen","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025081500464280200_CIT0026","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"key":"2025081500464280200_CIT0027","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/a-1164-1944","article-title":"The impact of glucocorticoid co-secretion in primary aldosteronism on thyroid autoantibody titers during the course of disease","volume":"52","author":"Handgriff","year":"2020","journal-title":"Horm Metab Res"},{"key":"2025081500464280200_CIT0028","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.atherosclerosis.2021.03.033","article-title":"Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism","volume":"324","author":"Haze","year":"2021","journal-title":"Atherosclerosis"},{"key":"2025081500464280200_CIT0029","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/HJH.0000000000000464","article-title":"Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness","volume":"33","author":"Holaj","year":"2015","journal-title":"J Hypertens"},{"key":"2025081500464280200_CIT0030","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"2025081500464280200_CIT0031","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/1470320314549220","article-title":"Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism","volume":"16","author":"Indra","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2025081500464280200_CIT0032","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2025081500464280200_CIT0033","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/HJH.0000000000002070","article-title":"Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism","volume":"37","author":"Katabami","year":"2019","journal-title":"J Hypertens"},{"key":"2025081500464280200_CIT0034","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-21-0018","article-title":"Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study","volume":"185","author":"K\u00f6hler","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2025081500464280200_CIT0035","doi-asserted-by":"crossref","first-page":"20406223221143233","DOI":"10.1177\/20406223221143233","article-title":"Mineralocorticoid receptor antagonist treatment improved arterial stiffness in patients with primary aldosteronism: a cohort study compared with adrenalectomy","volume":"14","author":"Liao","year":"2023","journal-title":"Ther Adv Chronic Dis"},{"key":"2025081500464280200_CIT0036","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3803\/EnM.2020.797","article-title":"Changes in glucose metabolism after adrenalectomy or treatment with a mineralocorticoid receptor antagonist for primary aldosteronism","volume":"35","author":"Lin","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2025081500464280200_CIT0037","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1507\/endocrj.EJ15-0362","article-title":"Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism","volume":"63","author":"Matsuda","year":"2016","journal-title":"Endocr J"},{"key":"2025081500464280200_CIT0038","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41371-019-0241-8","article-title":"Long-term blood pressure outcomes of patients with adrenal venous sampling-proven unilateral primary aldosteronism","volume":"34","author":"Meng","year":"2020","journal-title":"J Hum Hypertens"},{"key":"2025081500464280200_CIT0039","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1507\/endocrj.EJ16-0530","article-title":"Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism","volume":"64","author":"Park","year":"2017","journal-title":"Endocr J"},{"key":"2025081500464280200_CIT0040","first-page":"73","article-title":"Increasing rates of referrals for investigation of primary aldosteronism at a tertiary centre","volume":"136","author":"Park","year":"2023","journal-title":"N Z Med J"},{"key":"2025081500464280200_CIT0041","doi-asserted-by":"crossref","first-page":"916744","DOI":"10.3389\/fendo.2022.916744","article-title":"Treatment of primary aldosteronism and reversal of renin suppression improves left ventricular systolic function","volume":"13","author":"Puar","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025081500464280200_CIT0042","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cen.14351","article-title":"Outcomes in unilateral primary aldosteronism after surgical or medical therapy","volume":"94","author":"Puar","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025081500464280200_CIT0043","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"2025081500464280200_CIT0044","doi-asserted-by":"crossref","first-page":"bvaa011","DOI":"10.1210\/jendso\/bvaa011","article-title":"Basal plasma aldosterone concentration predicts therapeutic outcomes in primary aldosteronism","volume":"4","author":"Saiki","year":"2020","journal-title":"J Endocr Soc"},{"key":"2025081500464280200_CIT0045","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ajh.2008.243","article-title":"Adrenalectomy improves arterial stiffness in primary aldosteronism","volume":"21","author":"Strauch","year":"2008","journal-title":"Am J Hypertens"},{"key":"2025081500464280200_CIT0046","doi-asserted-by":"crossref","first-page":"503","DOI":"10.33549\/physiolres.930298","article-title":"Does the treatment of primary hyperaldosteronism influence glucose tolerance","volume":"52","author":"Strauch","year":"2003","journal-title":"Physiol Res"},{"key":"2025081500464280200_CIT0047","doi-asserted-by":"crossref","first-page":"e023813","DOI":"10.1161\/JAHA.121.023813","article-title":"Comparison of echocardiographic changes between surgery and medication treatment in patients with primary aldosteronism","volume":"11","author":"Ueda","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025081500464280200_CIT0048","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/cen.14836","article-title":"Prognostic value of contralateral suppression on kidney function after surgery in patients with primary aldosteronism","volume":"98","author":"Voss","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025081500464280200_CIT0049","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/jhh.2017.38","article-title":"Hyperkalemia in both surgically and medically treated patients with primary aldosteronism","volume":"31","author":"Wada","year":"2017","journal-title":"J Hum Hypertens"},{"key":"2025081500464280200_CIT0050","doi-asserted-by":"crossref","first-page":"e028146","DOI":"10.1161\/JAHA.122.028146","article-title":"Markers of kidney tubular function deteriorate while those of kidney tubule health improve in primary aldosteronism after targeted treatments","volume":"12","author":"Wu","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025081500464280200_CIT0051","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment","volume":"29","author":"Wu","year":"2011","journal-title":"J Hypertens"},{"key":"2025081500464280200_CIT0052","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","article-title":"[(11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial","volume":"29","author":"Wu","year":"2023","journal-title":"Nat Med"},{"key":"2025081500464280200_CIT0053","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11547-016-0662-1","article-title":"Comparison of radiofrequency ablation versus laparoscopic adrenalectomy for benign aldosterone-producing adenoma","volume":"121","author":"Yang","year":"2016","journal-title":"Radiol Med"},{"key":"2025081500464280200_CIT0054","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1089\/end.2013.0635","article-title":"Retroperitoneoscopic-guided cool-tip radiofrequency ablation of adrenocortical aldosteronoma","volume":"28","author":"Yang","year":"2014","journal-title":"J Endourol"},{"key":"2025081500464280200_CIT0055","doi-asserted-by":"crossref","first-page":"e2338209","DOI":"10.1001\/jamanetworkopen.2023.38209","article-title":"Corticotropin stimulation in adrenal venous sampling for patients with primary aldosteronism: the ADOPA randomized clinical trial","volume":"6","author":"Yang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2025081500464280200_CIT0056","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ajh\/hpac105","article-title":"Adrenal ablation versus mineralocorticoid receptor antagonism for the treatment of primary aldosteronism: a single-center prospective cohort study","volume":"35","author":"Zhou","year":"2022","journal-title":"Am J Hypertens"},{"key":"2025081500464280200_CIT0057","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41440-023-01420-w","article-title":"A controlled trial of percutaneous adrenal arterial embolization for hypertension in patients with idiopathic hyperaldosteronism","volume":"47","author":"Zhou","year":"2024","journal-title":"Hypertens Res"},{"key":"2025081500464280200_CIT0058","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12020-022-03029-4","article-title":"Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry","volume":"76","author":"Araujo-Castro","year":"2022","journal-title":"Endocrine"},{"key":"2025081500464280200_CIT0059","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s40618-023-02090-8","article-title":"Prevalence, risk factors and evolution of diabetes mellitus after treatment in primary aldosteronism. Results from the SPAIN-ALDO registry","volume":"46","author":"Araujo-Castro","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"2025081500464280200_CIT0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-21-0836","article-title":"Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments","volume":"186","author":"Wu","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2025081500464280200_CIT0061","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/SLA.0000000000006026","article-title":"Surgery for primary aldosteronism in France from 2010 to 2020 - results from the French-Speaking Association of Endocrine Surgery (AFCE): Eurocrine Study Group","volume":"278","author":"Vignaud","year":"2023","journal-title":"Ann Surg"},{"key":"2025081500464280200_CIT0062","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2025081500464280200_CIT0063","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.surg.2019.08.017","article-title":"Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism","volume":"167","author":"Chang","year":"2020","journal-title":"Surgery"},{"key":"2025081500464280200_CIT0064","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/s41440-022-00979-0","article-title":"Assessment of cardiovascular disease risk by plasma renin activity changes in patients with primary aldosteronism on mineralocorticoid receptor antagonist treatment","volume":"45","author":"Morimoto","year":"2022","journal-title":"Hypertens Res"},{"key":"2025081500464280200_CIT0065","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41440-023-01503-8","article-title":"The impact of superselective adrenal artery embolization on renal function in patients with primary aldosteronism: a prospective cohort study","volume":"47","author":"Lai","year":"2024","journal-title":"Hypertens Res"},{"key":"2025081500464280200_CIT0066","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: practical clinical perspectives","volume":"285","author":"Young","year":"2019","journal-title":"J Intern Med"},{"key":"2025081500464280200_CIT0067","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2025081500464280200_CIT0068","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"2025081500464280200_CIT0069","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/bmj.2.5860.216","article-title":"Amiloride in primary hyperaldosteronism with chronic peptic ulceration","volume":"2","author":"Kremer","year":"1973","journal-title":"Br Med J"},{"key":"2025081500464280200_CIT0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/HYPERTENSIONAHA.123.21910","article-title":"Multifocal, asymmetric bilateral primary aldosteronism cannot be excluded by strong adrenal vein sampling lateralization: an international retrospective cohort study","volume":"81","author":"Turcu","year":"2024","journal-title":"Hypertension"},{"key":"2025081500464280200_CIT0071","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025081500464280200_CIT0072","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5049\/EBP.2019.17.2.45","article-title":"Incidence of acute kidney injury after adrenalectomy in patients with primary aldosteronism","volume":"17","author":"Lee","year":"2019","journal-title":"Electrolyte Blood Press"},{"key":"2025081500464280200_CIT0073","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jvir.2019.04.039","article-title":"Effectiveness of thermal ablation for aldosterone-producing adrenal adenoma: a systematic review and meta-analysis of clinical and biochemical parameters","volume":"30","author":"Liang","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"2025081500464280200_CIT0074","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/s41440-024-01815-3","article-title":"Rationality and implication of catheter-based adrenal ablation for bilateral primary aldosteronism","volume":"47","author":"Sun","year":"2024","journal-title":"Hypertens Res"},{"key":"2025081500464280200_CIT0075","first-page":"256","article-title":"Successful therapeutic embolization of aldosteronoma using absolute ethanol","volume":"11","author":"Inoue","year":"1993","journal-title":"Radiat Med"},{"key":"2025081500464280200_CIT0076","doi-asserted-by":"crossref","first-page":"100029","DOI":"10.1016\/j.ijchy.2020.100029","article-title":"2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism","volume":"5","author":"Rossi","year":"2020","journal-title":"Int J Cardiol Hypertens"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaf029\/62440901\/hpaf029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/38\/9\/654\/62440901\/hpaf029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/38\/9\/654\/62440901\/hpaf029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T04:47:08Z","timestamp":1755233228000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/38\/9\/654\/8084669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":76,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,3,18]]},"published-print":{"date-parts":[[2025,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaf029","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,3,18]]}}}